On June 4, Medicare Rights Center President Fred Riccardi testified at a hearing of the House Committee on Energy and Commerce, Subcommittee on Health titled “Investing in America’s Health Care.”

The hearing examined an array of public health initiatives set to expire in September. Riccardi spoke to several of the Medicare-related programs, urging Congress to address these expirations in a health care “extenders” legislative package later this year.

Earlier this year, a federal government systems issue prevented Medicare Advantage and Part D premiums from being automatically deducted from the Social Security payments of some people with Medicare. Normally, if a beneficiary elects, Social Security deducts the premiums and sends them directly to the plan. In this instance, the payments were not sent to the plans, and beneficiaries did not know that their plans were not receiving them.

The US Government Accountability Office (GAO) released a report this week finding that the Centers for Medicare & Medicaid Services (CMS) is insufficiently open about Medicaid demonstrations. Demonstrations allow states to test new approaches to delivering services under the Medicaid Program. Currently, demonstrations account for nearly a third of Medicaid spending.

Drug prices have been in the news lately, and a timely analysis from the Kaiser Family Foundation gives valuable insight into prescription drug spending across large employer plans, Medicaid, and Medicare Part D. By understanding spending and prescribing patterns across these payers, policymakers can make better decisions about lowering the cost of medications for consumers.

This week, Centers for Medicare & Medicaid Services (CMS) released an “early look” at the 2017 Medicare Current Beneficiary Survey (MCBS) results, including preliminary estimates about the Medicare population. The MCBS targets the Medicare population that resides in “the community” and does not include individuals who live in a nursing facility.

The Centers for Medicare & Medicaid Services (CMS), the agency that oversees the Medicare and Medicaid programs, have put a rule in place that will change the look of television ads for prescription medications. Last week, CMS announced that most drugs that are covered by Medicare or Medicaid must soon include pricing information in their TV ads.

A new issue brief from the Kaiser Family Foundation indicates that people with Medicare who choose Medicare Advantage (MA) plans have lower Medicare spending and use fewer services relative to their peers with Original Medicare, even before they enroll in MA.

While most people newly eligible for Medicare are automatically enrolled in Part B—because they are collecting Social Security retirement benefits at age 65—a growing number are not, as they are working later in life and deferring their Social Security benefits. Unlike those who are auto-enrolled in Part B, these individuals must make an active Medicare enrollment choice, taking into consideration specific timelines and existing coverage.

The Medicare Trustee’s report underscores what we already know: Medicare is strong and built to last. We urge lawmakers to pursue commonsense reforms—like reversing the tax bill’s troubling trajectory, reigning in high prescription drug prices, and eliminating Medicare Advantage overpayments—to ensure it stays that way.

Last year, the Centers for Medicare & Medicaid Services (CMS), the federal agency that oversees the Medicare program, released a draft version of the annual “Medicare & You” handbook that contained several glaring inaccuracies. In a significant advocacy success, Medicare Rights and our allies convinced CMS to correct these major errors and release a final 2019 handbook that was greatly improved.